Neurophth found
in Wuhan, China
Prof. Bin Li (the founder of Neurophth) initiated gene therapy studies for Leber’s hereditary optic neuropathy (LHON) in 2008
IIT clinical data with the longest follow-up time and the largest sample size for LHON gene therapy has been accumulated since 2011
BUILDING A BRIGHTER FUTURE FOR PATIENTS
Becoming a World Leading Company in Ocular Gene Therapy
Subjects treated in
IIT studies initiated
by Prof. Bin Li